Abbott Labs Sues Zydus Over Depakote

Law360, New York (December 7, 2007, 12:00 AM EST) -- Abbott Laboratories has filed another patent suit to protect the billion-dollar U.S. market for the bipolar mania and epilepsy treatment Depakote, accusing Zydus Pharmaceuticals (USA) Inc. of infringing four patents related to controlled release formulations of Depakote's active ingredient.

Abbott filed its suit against New Jersey-based Zydus on Thursday, in the U.S. District Court for the District of New Jersey, seeking injunctive relief, attorneys' fees and costs, and a judgment that the asserted patents are valid, enforceable and infringed by the filing of Zydus' application for...
To view the full article, register now.